
    
      We expect to collect tissue samples from 270 pancreatic cancer patients of any stages. Since
      the enrollment criteria are not limited to new patients, we expect to enroll 67 patients a
      year. The patient enrollment will be completed in 4 years. Clinical follow-up will be
      completed in another one year. Data analysis and correlation study may be finished in the end
      of 5th year of this study.
    
  